Study Designs and Statistical Analyses for Biomarker Research

被引：52

作者：

Gosho, Masahiko ^{[1
]}

Nagashima, Kengo ^{[1
,2
]}

Sato, Yasunori ^{[3
]}

机构：

[1] Tokyo Univ Sci, Grad Sch Engn, Shinjuku Ku, Tokyo 1628601, Japan

[2] Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama 3500295, Japan

[3] Chiba Univ Med, Clin Res Ctr, Chuo Ku, Chiba 2608677, Japan

来源：

SENSORS | 2012年 / 12卷 / 07期

基金：

日本学术振兴会;

关键词：

biomarker adaptive design; confounding; multiplicity; predictive factor; statistical test; CLINICAL-TRIAL DESIGNS; FALSE DISCOVERY RATE; SURROGATE ENDPOINTS; GENE-EXPRESSION; BREAST-CANCER; LUNG-CANCER; VALIDATION; POLYMORPHISMS; CHEMOTHERAPY; PROGNOSIS;

D O I：

10.3390/s120708966

中图分类号：

O65 [分析化学];

学科分类号：

070302 ; 081704 ;

摘要：

Biomarkers are becoming increasingly important for streamlining drug discovery and development. In addition, biomarkers are widely expected to be used as a tool for disease diagnosis, personalized medication, and surrogate endpoints in clinical research. In this paper, we highlight several important aspects related to study design and statistical analysis for clinical research incorporating biomarkers. We describe the typical and current study designs for exploring, detecting, and utilizing biomarkers. Furthermore, we introduce statistical issues such as confounding and multiplicity for statistical tests in biomarker research.

引用

页码：8966 / 8986

页数：21

共 50 条

[41] BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses
Papadakis, E. S.
Reeves, T.
Robson, N. H.
Maishman, T.
Packham, G.
Cutress, R. I.
BRITISH JOURNAL OF CANCER, 2017, 116 (12) : 1585 - 1594
[42] Biomarker Research in World Journal of Oncology
Takabe, Kazuaki
Benesch, Matthew G. K.
WORLD JOURNAL OF ONCOLOGY, 2023, 14 (01) : 1 - 3
[43] Integrative biomarker analyses indicate etiological variations in hepatocellular carcinoma
Zhu, Andrew X.
Chen, David
He, Wei
Kanai, Masayuki
Voi, Maurizio
Chen, Li-Tzong
Daniele, Bruno
Furuse, Junji
Kang, Yoon-Koo
Poon, Ronnie T. P.
Vogel, Arndt
Chiang, Derek Y.
JOURNAL OF HEPATOLOGY, 2016, 65 (02) : 296 - 304
[44] Avoiding false discovery in biomarker research
Patel, Pranali
Kuzmanov, Uros
Mital, Seema
BMC BIOCHEMISTRY, 2016, 17
[45] Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study
Oaknin, Ana
Pothuri, Bhavana
Gilbert, Lucy
Sabatier, Renaud
Brown, Jubilee
Ghamande, Sharad
Mathews, Cara
O'Malley, David M.
Kristeleit, Rebecca
Boni, Valentina
Gravina, Adriano
Banerjee, Susana
Miller, Rowan
Pikiel, Joanna
Mirza, Mansoor R.
Dewal, Ninad
Antony, Grace
Dong, Yuping
Zografos, Eleftherios
Veneris, Jennifer
Tinker, Anna V.
CLINICAL CANCER RESEARCH, 2023, 29 (22) : 4564 - 4574
[46] Clinical Trial Designs for Predictive Biomarker Validation: Theoretical Considerations and Practical Challenges
Mandrekar, Sumithra J.
Sargent, Daniel J.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (24) : 4027 - 4034
[47] Optimal predictive probability designs for randomized biomarker-guided oncology trials
Zabor, Emily C.
Kaizer, Alexander M.
Pennell, Nathan A.
Hobbs, Brian P.
FRONTIERS IN ONCOLOGY, 2022, 12
[48] Evaluation of Heart Failure Biomarker Tests: A Survey of Statistical Considerations
De, Arkendra
Meier, Kristen
Tang, Rong
Li, Meijuan
Gwise, Thomas
Gomatam, Shanti
Pennello, Gene
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2013, 6 (04) : 449 - 457
[49] Selecting the most appropriate inferential statistical test for your quantitative research study
Bettany-Saltikov, Josette
Whittaker, Victoria Jane
JOURNAL OF CLINICAL NURSING, 2014, 23 (11-12) : 1520 - 1531
[50] Mixed Methods Research: Toward New Research Designs in Applied Linguistics
Hashemi, Mohammad R.
Babaii, Esmat
MODERN LANGUAGE JOURNAL, 2013, 97 (04) : 828 - 852

← 1 2 3 4 5 →